菸鹼醯胺單核苷酸 (NMN) Nicotinamide Mononucleotide (NMN)

INT-nicotinamide-mononucleotide-001 3 個適應症被研究
C 2 D 1

適應症與證據等級

法規與權威立場 (L4)

L4a · US FDA
立場:against
NMN is excluded from the definition of a dietary supplement
來源 ↗
L4b · EU EFSA
立場:neutral
EFSA considers a daily intake of 300 mg of NMN to be safe for the general population, excluding pregnant and lactating women.
來源 ↗
L4c · UK NHS
立場:not_addressed
L4d · TW TFDA / 衛福部
立場:cautious
違反食品安全衛生管理法第28條規定
來源 ↗
L4e · WHO
立場:not_addressed

市場與行銷 (L10)

L10a · TW Market Channels
BHK's 酵母NMN喚采 $790
L10b · TW Legal Identity (TFDA)
未紀載任何關於NMN的食品、藥品成分
L10c · TW Community (PTT/Dcard/Mobile01)
請問nmn是真的不老藥,還是智商稅?